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Eucalyptus is the second most planted tree on earth.
Despite this ranking, its mature breeding programs, clo-
nal propagation and deployment and short rotation time
make it a leading target for biotechnology improvement.
The recently completed eucalyptus genome project pro-
vides an enormous opportunity for understanding and
developing new traits for eucalyptus forestry. The main
obstacle for widespread trait enhancement remains the
recalcitrance of commercial eucalyptus clones to trans-
formation and thus the lack of a suitable prototyping
system for this species. We believe that the future suc-
cess of trait development in eucalyptus will be enhanced
by close collaboration between academic centers and
industrial partners. Some of FuturaGene’sm o d e l s
for academic collaboration will be described in this
presentation.
An example of such potential collaborations may
involve BRASUZ1, which constituted the germplasm
base for the eucalyptus genome project. This key clone
was donated by Suzano Pulp and Paper, FuturaGene’s
parent, to the genome project. We will present our pro-
gress with the transformation protocol for BRASUZ1,
which could provide a platform for collaborations. We
will also present our perspective on the development of
improved transgenic eucalyptus, and an outline for such
development programs.
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